EPO revokes Forward patent related to Tecfidera

Forward Pharma A/S (NASDAQ:FWP) said the European Patent Office revoked Forward's European Patent No. EP2801355, which Forward claims is infringed by blockbuster multiple sclerosis drug Tecfidera dimethyl fumarate

Read the full 280 word article

User Sign In